Moschetta A - Search Results

1

Atherosclerosis: lessons from LXR and the intestine.

Bonamassa B, Moschetta A. Bonamassa B, et al. Among authors: moschetta a. Trends Endocrinol Metab. 2013 Mar;24(3):120-8. doi: 10.1016/j.tem.2012.10.004. Epub 2012 Nov 15. Trends Endocrinol Metab. 2013. PMID: 23158108 Review.

2

Intestinal specific LXR activation stimulates reverse cholesterol transport and protects from atherosclerosis.

Lo Sasso G, Murzilli S, Salvatore L, D'Errico I, Petruzzelli M, Conca P, Jiang ZY, Calabresi L, Parini P, Moschetta A. Lo Sasso G, et al. Among authors: moschetta a. Cell Metab. 2010 Aug 4;12(2):187-93. doi: 10.1016/j.cmet.2010.07.002. Cell Metab. 2010. PMID: 20674863 Free article.

3

Nuclear receptor LXR as a novel therapeutic antitumoral target in glioblastoma.

Moschetta A. Moschetta A. Cancer Discov. 2011 Oct;1(5):381-2. doi: 10.1158/2159-8290.CD-11-0228. Cancer Discov. 2011. PMID: 22586629

4

Uncoupling nuclear receptor LXR and cholesterol metabolism in cancer.

Bovenga F, Sabbà C, Moschetta A. Bovenga F, et al. Among authors: moschetta a. Cell Metab. 2015 Apr 7;21(4):517-26. doi: 10.1016/j.cmet.2015.03.002. Cell Metab. 2015. PMID: 25863245 Free article. Review.

5

Down-regulation of the LXR transcriptome provides the requisite cholesterol levels to proliferating hepatocytes.

Lo Sasso G, Celli N, Caboni M, Murzilli S, Salvatore L, Morgano A, Vacca M, Pagliani T, Parini P, Moschetta A. Lo Sasso G, et al. Among authors: moschetta a. Hepatology. 2010 Apr;51(4):1334-44. doi: 10.1002/hep.23436. Hepatology. 2010. PMID: 20044803

6

Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasis.

Modica S, Petruzzelli M, Bellafante E, Murzilli S, Salvatore L, Celli N, Di Tullio G, Palasciano G, Moustafa T, Halilbasic E, Trauner M, Moschetta A. Modica S, et al. Among authors: moschetta a. Gastroenterology. 2012 Feb;142(2):355-65.e1-4. doi: 10.1053/j.gastro.2011.10.028. Epub 2011 Nov 2. Gastroenterology. 2012. PMID: 22057115

7

Liver X receptors inhibit proliferation of human colorectal cancer cells and growth of intestinal tumors in mice.

Lo Sasso G, Bovenga F, Murzilli S, Salvatore L, Di Tullio G, Martelli N, D'Orazio A, Rainaldi S, Vacca M, Mangia A, Palasciano G, Moschetta A. Lo Sasso G, et al. Among authors: moschetta a. Gastroenterology. 2013 Jun;144(7):1497-507, 1507.e1-13. doi: 10.1053/j.gastro.2013.02.005. Epub 2013 Feb 16. Gastroenterology. 2013. PMID: 23419360

8

Nuclear bile acid receptor FXR as pharmacological target: are we there yet?

Modica S, Moschetta A. Modica S, et al. Among authors: moschetta a. FEBS Lett. 2006 Oct 9;580(23):5492-9. doi: 10.1016/j.febslet.2006.07.082. Epub 2006 Aug 8. FEBS Lett. 2006. PMID: 16904670 Free article. Review.

9

Bile acids and colon cancer: Solving the puzzle with nuclear receptors.

Degirolamo C, Modica S, Palasciano G, Moschetta A. Degirolamo C, et al. Among authors: moschetta a. Trends Mol Med. 2011 Oct;17(10):564-72. doi: 10.1016/j.molmed.2011.05.010. Epub 2011 Jul 2. Trends Mol Med. 2011. PMID: 21724466 Review.

10

Deciphering the nuclear bile acid receptor FXR paradigm.

Modica S, Gadaleta RM, Moschetta A. Modica S, et al. Among authors: moschetta a. Nucl Recept Signal. 2010 Nov 19;8:e005. doi: 10.1621/nrs.08005. Nucl Recept Signal. 2010. PMID: 21383957 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

205 results

Search Page